These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31451313)

  • 1. The respiratory microbiota: associations with influenza symptomatology and viral shedding.
    Lee KH; Foxman B; Kuan G; López R; Shedden K; Ng S; Balmaseda A; Gordon A
    Ann Epidemiol; 2019 Sep; 37():51-56.e6. PubMed ID: 31451313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of oseltamivir treatment on duration of clinical illness and viral shedding and household transmission of influenza virus.
    Ng S; Cowling BJ; Fang VJ; Chan KH; Ip DK; Cheng CK; Uyeki TM; Houck PM; Malik Peiris JS; Leung GM
    Clin Infect Dis; 2010 Mar; 50(5):707-14. PubMed ID: 20121573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Oseltamivir Treatment With Virus Shedding, Illness, and Household Transmission of Influenza Viruses.
    Cheung DH; Tsang TK; Fang VJ; Xu J; Chan KH; Ip DK; Peiris JS; Leung GM; Cowling BJ
    J Infect Dis; 2015 Aug; 212(3):391-6. PubMed ID: 25646354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial.
    Welliver R; Monto AS; Carewicz O; Schatteman E; Hassman M; Hedrick J; Jackson HC; Huson L; Ward P; Oxford JS;
    JAMA; 2001 Feb; 285(6):748-54. PubMed ID: 11176912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral Shedding and Transmission Potential of Asymptomatic and Paucisymptomatic Influenza Virus Infections in the Community.
    Ip DK; Lau LL; Leung NH; Fang VJ; Chan KH; Chu DK; Leung GM; Peiris JS; Uyeki TM; Cowling BJ
    Clin Infect Dis; 2017 Mar; 64(6):736-742. PubMed ID: 28011603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China.
    Yu H; Liao Q; Yuan Y; Zhou L; Xiang N; Huai Y; Guo X; Zheng Y; van Doorn HR; Farrar J; Gao Z; Feng Z; Wang Y; Yang W
    BMJ; 2010 Sep; 341():c4779. PubMed ID: 20876641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duration of viral shedding of influenza A (H1N1) virus infection treated with oseltamivir and/or traditional Chinese medicine in China: a retrospective analysis.
    Wang YG; Jiang M; Wang RB; Zha QL; Zhang SJ; Zhou GQ; Li XW; Wang YY; Lv AP
    J Tradit Chin Med; 2012 Jun; 32(2):148-55. PubMed ID: 22876436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial.
    Fry AM; Goswami D; Nahar K; Sharmin AT; Rahman M; Gubareva L; Azim T; Bresee J; Luby SP; Brooks WA
    Lancet Infect Dis; 2014 Feb; 14(2):109-18. PubMed ID: 24268590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virus shedding and environmental deposition of novel A (H1N1) pandemic influenza virus: interim findings.
    Killingley B; Greatorex J; Cauchemez S; Enstone JE; Curran M; Read RC; Lim WS; Hayward A; Nicholson KG; Nguyen-Van-Tam JS
    Health Technol Assess; 2010 Oct; 14(46):237-354. PubMed ID: 20923613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of human influenza A(H7N9) infection in Hong Kong.
    Leung YH; To MK; Lam TS; Yau SW; Leung OS; Chuang SK
    J Microbiol Immunol Infect; 2017 Apr; 50(2):183-188. PubMed ID: 26220305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors promoting the prolonged shedding of the pandemic (H1N1) 2009 influenza virus in patients treated with oseltamivir for 5 days.
    Ryoo SM; Kim WY; Sohn CH; Seo DW; Oh BJ; Lee JH; Lee YS; Lim KS
    Influenza Other Respir Viruses; 2013 Sep; 7(5):833-7. PubMed ID: 23279949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The respiratory microbiome and susceptibility to influenza virus infection.
    Lee KH; Gordon A; Shedden K; Kuan G; Ng S; Balmaseda A; Foxman B
    PLoS One; 2019; 14(1):e0207898. PubMed ID: 30625134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity Increases the Duration of Influenza A Virus Shedding in Adults.
    Maier HE; Lopez R; Sanchez N; Ng S; Gresh L; Ojeda S; Burger-Calderon R; Kuan G; Harris E; Balmaseda A; Gordon A
    J Infect Dis; 2018 Sep; 218(9):1378-1382. PubMed ID: 30085119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection.
    Ling LM; Chow AL; Lye DC; Tan AS; Krishnan P; Cui L; Win NN; Chan M; Lim PL; Lee CC; Leo YS
    Clin Infect Dis; 2010 Apr; 50(7):963-9. PubMed ID: 20180701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza A Virus Shedding and Infectivity in Households.
    Tsang TK; Cowling BJ; Fang VJ; Chan KH; Ip DK; Leung GM; Peiris JS; Cauchemez S
    J Infect Dis; 2015 Nov; 212(9):1420-8. PubMed ID: 25883385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of drug-resistant viruses and virus shedding in pediatric influenza patients treated with neuraminidase inhibitors.
    Tamura D; Sugaya N; Ozawa M; Takano R; Ichikawa M; Yamazaki M; Kawakami C; Shimizu H; Uehara R; Kiso M; Kawakami E; Mitamura K; Kawaoka Y
    Clin Infect Dis; 2011 Feb; 52(4):432-7. PubMed ID: 21248368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pandemic H1N1 virus transmission and shedding dynamics in index case households of a prospective Vietnamese cohort.
    Thai PQ; Mai le Q; Welkers MR; Hang Nle K; Thanh le T; Dung VT; Yen NT; Duong TN; Hoa le NM; Thoang DD; Trang HT; de Jong MD; Wertheim H; Hien NT; Horby P; Fox A
    J Infect; 2014 Jun; 68(6):581-90. PubMed ID: 24491598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-existing Antineuraminidase Antibodies Are Associated With Shortened Duration of Influenza A(H1N1)pdm Virus Shedding and Illness in Naturally Infected Adults.
    Maier HE; Nachbagauer R; Kuan G; Ng S; Lopez R; Sanchez N; Stadlbauer D; Gresh L; Schiller A; Rajabhathor A; Ojeda S; Guglia AF; Amanat F; Balmaseda A; Krammer F; Gordon A
    Clin Infect Dis; 2020 May; 70(11):2290-2297. PubMed ID: 31300819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of oseltamivir treatment of index patients with influenza on secondary household illness in an urban setting in Bangladesh: secondary analysis of a randomised, placebo-controlled trial.
    Fry AM; Goswami D; Nahar K; Sharmin AT; Rahman M; Gubareva L; Trujillo A; Barnes J; Azim T; Bresee J; Luby SP; Brooks WA
    Lancet Infect Dis; 2015 Jun; 15(6):654-62. PubMed ID: 25788164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pandemic Influenza A (H1N1) 2009 in India: duration of virus shedding in patients under antiviral treatment.
    Gandhoke I; Rawat DS; Rai A; Khare S; Ichhpujani RL
    Indian J Med Microbiol; 2011; 29(1):37-41. PubMed ID: 21304193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.